Growth Hormone (GH) and Adult Bone Remodeling: The Potential Use of GH in Treatment of Osteoporosis
暂无分享,去创建一个
L. Mosekilde | L. Mosekilde | A. Flyvbjerg | K. Brixen | E. Eriksen | M. Kassem | H. K. Nielsen | M. Kassem | H. Nielsen | Kim Brixen, | Allan Flyvbjerg, | Leif Mosekilde,
[1] L. Mosekilde,et al. Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin and glucagon. , 1992, Acta endocrinologica.
[2] S. Ljunghall,et al. Low plasma levels of insulin‐like growth factor 1 (IGF‐1) in male patients with idiopathic osteoporosis , 1992, Journal of internal medicine.
[3] K. Gould,et al. Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration. , 1992, The Journal of clinical endocrinology and metabolism.
[4] K. Takaoka,et al. Development of a monoclonal antibody specific for human bone alkaline phosphatase. , 1992, Bone and mineral.
[5] J. Cassella,et al. Abnormal collagen and mineral formation in osteogenesis imperfecta. , 1992, Bone and mineral.
[6] S. Lamberts,et al. The effects of recombinant human growth hormone (rhGH) on bone turnover and bone mass in growth hormone (GH) deficient patients , 1992 .
[7] M. Ranke,et al. Decreased insulin-like growth factors 1 and 2 in sera of patients with osteoporosis , 1992 .
[8] G. Brabant,et al. Increased bone mass with the combination therapy of hPTH(1–38) and rhGH in osteoporotic patients , 1992 .
[9] S. Gonnelli,et al. Human recombinant growth hormone with and without salmon calcitonin in the treatment of postmenopausal osteoporosis , 1992 .
[10] L. Mosekilde,et al. Effect of biosynthetic human growth hormone on biochemical markers of bone turnover — A dose response study in postmenopausal women with osteopenia , 1992 .
[11] C. Hassager,et al. The effect of growth hormone (GH) therapy on urinary pyridinoline cross‐links in GH‐deficient adults , 1991, Clinical endocrinology.
[12] S. Mohan,et al. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. , 1991, Endocrinology.
[13] S. Duursma,et al. Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells. , 1991, Growth regulation.
[14] L. Tatò,et al. Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. , 1991, The Journal of pediatrics.
[15] G. Rodan,et al. Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control. , 1991, Molecular endocrinology.
[16] F. Liu,et al. Further characterization of insulin-like-growth factor binding proteins in rat osteoblast-like cell cultures: modulation by 17 beta-estradiol and human growth hormone. , 1991, Endocrinology.
[17] S. Mohan,et al. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. , 1991, Biochemical and biophysical research communications.
[18] J. Wergedal,et al. Insulinlike growth factor II and transforming growth factor β regulate collagen expression in human osteoblastlike cells in vitro , 1991 .
[19] L. Mosekilde,et al. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] R. Eastell,et al. Cancellous bone remodeling in type i (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] R. Marcus,et al. Effects of short term administration of recombinant human growth hormone to elderly people. , 1990, The Journal of clinical endocrinology and metabolism.
[22] S. Mohan,et al. Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] S. Mohan,et al. Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. , 1990, Metabolism: clinical and experimental.
[24] P. Delmas,et al. Insulin like growth factor I hormonal regulation by growth hormone and by 1,25(OH)2D3 and activity on human osteoblast-like cells in short-term cultures. , 1990, Bone.
[25] V. Mitev,et al. [Insulin-like growth factors]. , 1990, Eksperimentalna meditsina i morfologiia.
[26] S. P. Chow,et al. 25-Hydroxycholecalciferol and insulin-like growth factor I are determinants of serum concentration of osteocalcin in elderly subjects with and without spinal fractures. , 1990, Bone.
[27] Obert,et al. Effects of human growth hormone in men over 60 years old. , 1990, The New England journal of medicine.
[28] S. Posen,et al. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. , 1989, Annals of internal medicine.
[29] D. Rowe,et al. Insulin-like growth factor I regulates type I procollagen messenger ribonucleic acid steady state levels in bone of rats. , 1989, Endocrinology.
[30] G. Rodan,et al. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. , 1989, Endocrinology.
[31] P. Marie,et al. Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. , 1989, The Journal of clinical endocrinology and metabolism.
[32] E. Canalis,et al. Insulin-like growth factor (IGF) and bone. , 1989, Connective tissue research.
[33] P Franchimont,et al. Effects of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like growth factor I, and bone metabolism in postmenopausal women. , 1989, Acta endocrinologica.
[34] E. Canalis,et al. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. , 1989, The Journal of clinical investigation.
[35] E. Froesch,et al. Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. , 1988, Biochemical and biophysical research communications.
[36] E. Canalis,et al. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. , 1988, Endocrinology.
[37] J. Aloia,et al. Treatment of osteoporosis with calcitonin, with and without growth hormone. , 1985, Metabolism: clinical and experimental.
[38] R L Hintz,et al. Insulin-like growth factors I and II: aging and bone density in women. , 1984, The Journal of clinical endocrinology and metabolism.
[39] J. Dequeker,et al. Dynamics of growth hormone secretion in patients with osteoporosis and in patients with osteoarthrosis. , 1982, Hormone research.
[40] F. Melsen,et al. Iliac crest bone mass and remodelling in acromegaly. , 1981, Acta endocrinologica.
[41] M. Kutner,et al. Impaired growth hormone secretion in the adult population: relation to age and adiposity. , 1981, The Journal of clinical investigation.
[42] J. Halse,et al. Total and non-dialyzable urinary hydroxyproline in acromegalics and control subjects. , 1981, Acta endocrinologica.
[43] R. Mazess,et al. Bone mineral status in growth hormone deficiency. , 1980, The Journal of pediatrics.
[44] F. Carrera,et al. The role of growth hormone in the pathogenesis of postmenopausal osteoporosis. , 1980, Archives of Internal Medicine.
[45] J. Aloia,et al. Effects of growth hormone in osteoporosis. , 1976, The Journal of clinical endocrinology and metabolism.
[46] J. Aloia,et al. Skeletal metabolism and body composition in acromegaly. , 1972, The Journal of clinical endocrinology and metabolism.
[47] P. Kelly,et al. The nature of the metabolic bone disorder in acromegaly. , 1972, The Journal of laboratory and clinical medicine.